EZH2 is essential for development of mouse preimplantation embryos

Area of Science:

• Developmental Biology
• Epigenetics
• Genetics

Background:

• Enhancer of zeste homologue 2 (Ezh2) plays a vital role in early mouse embryonic development.
• Loss of Ezh2 function leads to embryonic lethality and developmental defects in mice.
• Ezh2 deficiency affects embryonic stem cell establishment and trophoblast differentiation.

Purpose of the Study:

• To investigate the precise role of Ezh2 in early preimplantation mouse embryo development.
• To determine if Ezh2 is required for de novo protein synthesis during post-fertilization stages.
• To analyze the impact of Ezh2 loss on pluripotency markers, germ layer differentiation, and apoptosis.

Main Methods:

• Treatment of zygotes with cycloheximide (CHX) to inhibit de novo EZH2 protein synthesis.
• Microinjection of short interfering RNA (siRNA) targeting Ezh2 in preimplantation embryos.
• Analysis of blastocyst formation, pluripotency marker expression (Oct4, Sox2, Nanog), and apoptosis.
• Assessment of histone H3-Lysine 27 di- and tri-methylation (H3K27me2/3) levels.

Main Results:

• Inhibition of de novo EZH2 synthesis in zygotes suggests its requirement post-fertilization.
• Ezh2 loss at the pronuclear stage caused severe growth retardation and reduced blastocyst formation.
• Ezh2 knockdown led to decreased expression of pluripotency markers (Oct4, Sox2, Nanog).
• Upregulated expression of germ layer differentiation genes (Gata6, Hoxb1, Hand1) and increased apoptosis were observed.
• Reduced H3K27me2/3 modifications were noted in Ezh2 siRNA embryos.

Conclusions:

• Ezh2 is essential for normal preimplantation mouse embryo development.
• Ezh2 regulates key developmental processes including pluripotency, differentiation, and apoptosis.
• Epigenetic modifications, specifically H3K27me2/3, are critical downstream targets of Ezh2 in early embryogenesis.